اركوكسيا 90 مجم 28 قرص
اركوكسيا 90 مجم 28 قرص
موف سبراي 150 مل

موف سبراي 150 مل

اركوكسيا 120 مجم 7 أقراص

اركوكسيا 120 مجم 7 أقراص

اركوكسيا 90 مجم 28 قرص

٦٫٥٩ د.ك.‏
يساعد اركوكسيا 90 على تقليل الألم والتورم (الالتهاب) في مفاصل وعضلات الأشخاص الذين تبلغ أعمارهم 16 عاماً فما فوق كما يستخدم لمرضى النقرس.
الاتاحة: متوفر بالمتجر
SKU
170222

Arcoxia 90 mg 28 Tablets
It contains Etoricoxib which is:
A selective cox-2 inhibitor [NSAID] that has no effect on platelet function either inhibits gastric prostaglandin synthesis. It has anti-inflammatory and anti-rheumatoid effects.

Indications of arcoxia 90 mg :
• Rheumatoid arthritis and osteoarthritis.
• Ankylosing spondylitis.
• Relief of chronic musculoskeletal pain.
• Relief of acute pain.
• Acute gouty arthritis.

Points of interest:
• Do not take aspirin for pain relief while using this medication.
• Do not take this medication if you are dehydrated, due to severe vomiting or diarrhea.
• Stop this medication and tell your doctor immediately if you develop swollen ankles, difficulty in breathing, chest pain, black stools, or dark vomit.

How to use arcoxia 90 mg :
1 tablet daily after meal.

Active Ingredients:
Etoricoxib.

Side effects:
• Dizziness.
• High blood pressure.
• Palpitations.
• Fluid retention.
• Raised liver enzymes.

Cautions:
• Patients with most at risk of developing GIT complications.
• Patients with significant risk factors for cardiovascular diseases should only be treated with etoricoxib with special and careful consideration.
• Administration of etoricoxib may impair renal function, especially under conditions of compromised renal perfusion.
• Any patients with any signs or symptoms of liver dysfunction or in whom an abnormal liver function test has occurred should be monitored.
• Etoricoxb should be discontinued in patients with abnormal liver function tests (3x upper the limit of normal).
• Contraindicated in patients with active peptic ulceration/ GI bleeding.
• Contraindicated in patients with active sulfonamide sensitivity.
• Contraindicated in patients with severe hepatic dysfunction.
• Contraindicated in patients with inflammatory bowel disease.
• Contraindicated in patients with renal impairment.

Interactions:
• Rifamycins: The plasma concentration of etoricoxib is reduced by rifamycins.
• Ethinylestradiol: etoricoxib increases the plasma concentration of ethinylestradiol.
• Digoxin: etoricoxib increases the plasma concentration of digoxin.

معلومات اكثر
العلامة التجاريةMSD
WhatsApp Chat WhatsApp Chat